The in-vitro assay indicated that the generated Pep-4 Cy5.5 NP was able to deliver Pep-4 neo-peptide to HLA-A*2402 tumor cells in the presence of MMP2/MMP9. The gene discussed is HLA-A; the disease is neoplasm.